看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | 133.4x - 147.4x | 140.4x |
| Selected Fwd P/E Multiple | -17.7x - -19.6x | -18.6x |
| Fair Value | ₹17.53 - ₹19.38 | ₹18.46 |
| Upside | -29.6% - -22.1% | -25.8% |
| Benchmarks | - | Full Ticker |
| Ashtasidhhi Industries Limited | 53,134,100.0% | BSE:531341 |
| CSL Finance Limited | 53,006,700.0% | BSE:530067 |
| Agarwal Fortune India Limited | 53,076,500.0% | BSE:530765 |
| Chemo Pharma Laboratories Limited | 50,636,500.0% | BSE:506365 |
| Step Two Corporation Limited | 53,150,900.0% | BSE:531509 |
| Indergiri Finance Limited | 53,150,500.0% | BSE:531505 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| 531341 | 530067 | 530765 | 506365 | 531509 | 531505 | |||
| BSE:531341 | BSE:530067 | BSE:530765 | BSE:506365 | BSE:531509 | BSE:531505 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | 21.6% | -36.7% | 42.2% | NM- | NM- | ||
| 3Y CAGR | NM- | 32.0% | NM- | 68.7% | NM- | NM- | ||
| Latest Twelve Months | -691.5% | 26.5% | 755.6% | -70.9% | -350.5% | 105.6% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 14.2% | 39.8% | -791.0% | 52.0% | 20.8% | -27.2% | ||
| Prior Fiscal Year | 14.4% | 38.8% | 1.2% | 16.0% | 54.8% | 1.3% | ||
| Latest Fiscal Year | -49.8% | 38.0% | 1.3% | 65.3% | -35.5% | -93.3% | ||
| Latest Twelve Months | -22.5% | 34.8% | 2.2% | 37.9% | -189.0% | 2.4% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | NA | 7.1x | 54.2x | 14.7x | -2.9x | 29.1x | ||
| Price / LTM Sales | 6.7x | 2.9x | 1.8x | 18.5x | 7.3x | 6.3x | ||
| LTM P/E Ratio | -29.7x | 8.3x | 80.8x | 48.8x | -3.9x | 266.9x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -29.7x | 8.3x | 80.8x | |||||
| Historical LTM P/E Ratio | -33.5x | 23.5x | 168.5x | |||||
| Selected P/E Multiple | 133.4x | 140.4x | 147.4x | |||||
| (x) LTM Net Income | 0 | 0 | 0 | |||||
| (=) Equity Value | 63 | 66 | 70 | |||||
| (/) Shares Outstanding | 5.1 | 5.1 | 5.1 | |||||
| Implied Value Range | 12.44 | 13.10 | 13.75 | |||||
| FX Rate: INR/INR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 12.44 | 13.10 | 13.75 | 24.89 | ||||
| Upside / (Downside) | -50.0% | -47.4% | -44.8% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 531341 | 530067 | 530765 | 506365 | 531509 | 531505 | |
| Value of Common Equity | 119 | 6,128 | 77 | 194 | 155 | 126 | |
| (/) Shares Outstanding | 7.5 | 22.5 | 3.4 | 1.5 | 4.2 | 5.1 | |
| Implied Stock Price | 15.80 | 272.90 | 22.49 | 129.60 | 36.40 | 24.89 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 15.80 | 272.90 | 22.49 | 129.60 | 36.40 | 24.89 | |
| Trading Currency | INR | INR | INR | INR | INR | INR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |